Promising results for Atrial Fibrillation | UnityPoint Health
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
US pulsed field ablation market revenue exceeds $500m in 2024
"US pulsed field ablation market revenue exceeds $500m in 2024" was originally created and published by Medical Device ...
Science Daily4d
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
Hometown Source1d
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent atrial fibrillation
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent ...
Medindia4d
New Blood Thinner Reduces Bleeding Risk in Atrial Fibrillation Patients
Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.
Why is obesity linked to irregular heart rhythms? Researchers found one potential mechanism
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...